Drug induced changes in pigmentation.
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000962:Antimalarials / Q000009:adverse effects; D001151:Arsenic / Q000009:adverse effects; D001729:Bismuth / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D006046:Gold / Q000009:adverse effects; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D008628:Mercury / Q000009:adverse effects; D010619:Phenazines / Q000009:adverse effects; D010635:Phenolphthaleins / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D010859:Pigmentation Disorders / Q000139:chemically induced*; D012834:Silver / Q000009:adverse effects; D013450:Sulfones / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D003276:Contraceptives, Oral; D006827:Hydantoins; D010619:Phenazines; D010635:Phenolphthaleins; D010640:Phenothiazines; D013450:Sulfones; D001761:Bleomycin; D012834:Silver; D006046:Gold; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D008628:Mercury; D002066:Busulfan; D001151:Arsenic; D001729:Bismuth; D002746:Chlorpromazine